Across defense systems, diagnostics startups and a San Francisco drug-discovery company, Michael Farmer made a career of turning technical possibility into an operating business.

The Tradespace co-founder spent years watching valuable ideas stall inside corporate portfolios. Now he is building an AI-native operating model that moves patent work in-house and puts strategy ahead of paperwork.
He does not develop the drug or run the ads. He makes sure the thing gets made, on spec, on time, batch after batch - across a network of factories Takeda does not own.
Tim Bernstein is the CEO of yet2, an open innovation and technology scouting firm founded in 1999 with backing from DuPont, Procter & Gamble, Honeywell and Siemens. He joined the company in 2001, rose from operator to chief executive, and now spends his days matching corporate R&D needs with technologies and partners pulled from a database of more than five million solution providers. A Yale economist with a Stanford MBA and a Harvard Kennedy School policy degree, he turned an academic thesis on university licensing into a career spent brokering deals others could not find.

The XLSCOUT CEO learned intellectual property from the transaction side - engineering, technology transfer, licensing and acquisition. Now he is betting that patent-trained AI can make difficult work faster without pretending the domain is simple.